VJHemOnc is committed to improving our service to you

EHA 2019 | Current CML treatments: which TKI to choose?

VJHemOnc is committed to improving our service to you

Gianantonio Rosti

Gianantonio Rosti, MD, Institute of Hematology ‘Seragnoli’, Bologna, Italy, discusses the current landscape of chronic myeloid leukemia (CML) treatment, as well as the importance of consistent long-term monitoring. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter